BNP Paribas Financial Markets Sells 192,765 Shares of Astera Labs, Inc. $ALAB

Key Points

• BNP Paribas Financial Markets reduced its holdings in Astera Labs by 23.6% in the first quarter, now owning approximately 0.38% of the company with a total value of $37.2 million.
• CEO Jitendra Mohan and CFO Michael Truett Tate both sold significant shares on August 7, resulting in a 25.31% and 16.16% decrease in their respective stock ownership.
• A number of analysts have revised their price targets for Astera Labs stock, with Evercore ISI setting a target of $215.00 and Susquehanna raising theirs to $125.00.

BNP Paribas Financial Markets reduced its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 23.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 623,854 shares of the company's stock after selling 192,765 shares during the quarter. BNP Paribas Financial Markets owned 0.38% of Astera Labs worth $37,225,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Astera Labs by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after acquiring an additional 85,846 shares in the last quarter. Driehaus Capital Management LLC grew its holdings in shares of Astera Labs by 16,640.4% during the 4th quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock valued at $175,408,000 after acquiring an additional 1,316,419 shares in the last quarter. Bank of Nova Scotia grew its holdings in shares of Astera Labs by 3,742.2% during the 1st quarter. Bank of Nova Scotia now owns 964,400 shares of the company's stock valued at $57,546,000 after acquiring an additional 939,300 shares in the last quarter. Polar Capital Holdings Plc purchased a new position in shares of Astera Labs during the 4th quarter valued at $126,812,000. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in shares of Astera Labs by 25.2% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 636,536 shares of the company's stock valued at $37,982,000 after acquiring an additional 128,163 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 91,441 shares of the firm's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the transaction, the chief executive officer owned 2,170,877 shares in the company, valued at $398,377,638.27. This trade represents a 4.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Michael Truett Tate sold 18,861 shares of the company's stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $3,461,182.11. Following the completion of the sale, the chief financial officer owned 259,512 shares in the company, valued at $47,623,047.12. This trade represents a 6.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,649,489 shares of company stock valued at $232,463,986 over the last 90 days. Company insiders own 12.50% of the company's stock.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB traded up $2.44 during trading on Wednesday, hitting $176.68. 2,038,931 shares of the stock were exchanged, compared to its average volume of 4,918,402. The company has a market capitalization of $29.37 billion, a price-to-earnings ratio of 316.06, a price-to-earnings-growth ratio of 4.62 and a beta of 1.48. Astera Labs, Inc. has a 1-year low of $36.85 and a 1-year high of $199.47. The company's fifty day simple moving average is $136.10 and its 200-day simple moving average is $96.96.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. During the same period last year, the business earned $0.13 earnings per share. Astera Labs's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several research analyst reports. Needham & Company LLC boosted their price target on shares of Astera Labs from $100.00 to $170.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a report on Tuesday. Susquehanna upped their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a report on Thursday, August 7th. CICC Research started coverage on shares of Astera Labs in a report on Friday, August 29th. They issued an "outperform" rating and a $190.00 price objective for the company. Finally, Barclays reissued an "overweight" rating and set a $155.00 target price (up previously from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $142.00.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.